Blue Copper 5 Anti-Aging Body Lift — Clinical Results

Clinical Results

Blue Copper 5 Anti-Aging Body Lift

Built on a clinically dosed stretch-mark peptide — carried at the level used in the research, with published results. Here is the evidence.

What users saw in 8 weeks

Before
Before using Blue Copper 5 Anti-Aging Body Lift
After 8 weeks
After 8 weeks of Blue Copper 5 Anti-Aging Body Lift

Photography of an individual user following twice-daily use for 8 weeks. Individual results vary.

94%

saw smoother, firmer body skin

98%

saw improved stretch-mark appearance

94%

said skin felt more elastic

100%

would recommend it

Consumer perception study over 8 weeks of twice-daily use.

The ingredient evidence

Stretch-mark peptide complex

Clinically dosed — an exact match to the studied level

A peptide-based active developed to target stretch marks by protecting the dermal matrix from enzymatic breakdown while stimulating the synthesis of new structural proteins.

Clinical result (2 months) Figure
Decrease in stretch-mark depth -72%
Decrease in stretch-mark width -27%
Decrease in rough appearance -22%
Increase in dermal thickness +11%

Method: Clinical trial on 13 subjects with stretch marks less than 4 months post-partum; the active applied for 2 months. Supplier clinical study of the ingredient; not conducted on the finished Osmotics product.

Laboratory evidence

In-vitro, same dossier

In fibroblast culture, the same active increased the synthesis of the skin’s structural proteins and strongly inhibited the enzymes that degrade them.

Measure Result
Collagen I synthesis +102%
Fibronectin synthesis +91%
Elastase inhibition 66–90%

Method: In-vitro fibroblast culture study by the ingredient manufacturer. Laboratory results; not a measure of results on human skin.

Blue Copper (prezatide copper acetate) + matrikine peptides

Clinically dosed

Body Lift pairs the stretch-mark peptide with the copper peptide Osmotics pioneered in 1998 and the matrikine collagen-signalling duo — the same firming architecture as our facial heroes, formulated for the body.

References: Maquart et al., FEBS Letters, 1988 — stimulation of collagen synthesis in fibroblast cultures by GHK-Cu; supplier clinical dossier for the matrikine complex.